Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: A single-centre, open-label, dose-finding, non-randomised, phase 1b trial

Timothy M. Nywening, Andrea Wang-Gillam, Dominic E. Sanford, Brian A. Belt, Roheena Z. Panni, Brian M. Cusworth, Adetunji T. Toriola, Rebecca K. Nieman, Lori A. Worley, Motoyo Yano, Kathryn J. Fowler, A. Craig Lockhart, Rama Suresh, Benjamin R. Tan, Kian Huat Lim, Ryan C. Fields, Steven M. Strasberg, William G. Hawkins, David G. DeNardo, S. Peter GoedegebuureDavid C. Linehan

Research output: Contribution to journalArticlepeer-review

432 Scopus citations

Fingerprint

Dive into the research topics of 'Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: A single-centre, open-label, dose-finding, non-randomised, phase 1b trial'. Together they form a unique fingerprint.

Medicine & Life Sciences